Shapiro, Howard

Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results

Kaiser, P. K., Brown, D. M., Zhang, K., Hudson, H. L., Holz, F. G., Shapiro, H., Schneider, S., & Acharya, N. R. (2007) · American Journal of Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 361

Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶

Chen, Q., Huang, Z., Chen, H., Shapiro, H., Beckers, J., & Hetzel, F. W. (2007) · Photochemistry and Photobiology

Photodynamic Therapy Research StudiesNanoplatforms for cancer theranostics

Cited by 124

Duration and distance of exposure are important predictors of transmission among community contacts of Ontario SARS cases

REA, E., LAFLÈCHE, J., STALKER, S., GUARDA, B. K., SHAPIRO, H., JOHNSON, I., BONDY, S. J., UPSHUR, R., RUSSELL, M. L., & ELIASZIW, M. (2007) · Epidemiology and Infection

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 44

Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration

Hariprasad, S. M., Morse, L. S., Shapiro, H., Wong, P., & Tuomi, L. (2012) · Journal of Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 20